US 12,350,282 B2
Compositions and methods of treating acne and photoaging
David Lortscher, San Diego, CA (US)
Assigned to Curology, Inc., San Diego, CA (US)
Filed by Curology, Inc., San Diego, CA (US)
Filed on Apr. 20, 2023, as Appl. No. 18/304,061.
Application 18/304,061 is a continuation of application No. 16/860,768, filed on Apr. 28, 2020, granted, now 11,666,591, issued on Jun. 6, 2023.
Application 16/860,768 is a continuation of application No. 16/037,703, filed on Jul. 17, 2018, granted, now 10,668,095, issued on Jun. 2, 2020.
Application 16/037,703 is a continuation of application No. 15/223,229, filed on Jul. 29, 2016, granted, now 10,064,884, issued on Sep. 4, 2018.
Claims priority of provisional application 62/199,092, filed on Jul. 30, 2015.
Prior Publication US 2023/0372380 A1, Nov. 23, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/7056 (2006.01); A61K 8/36 (2006.01); A61K 8/362 (2006.01); A61K 8/49 (2006.01); A61K 8/55 (2006.01); A61K 8/58 (2006.01); A61K 8/60 (2006.01); A61K 9/00 (2006.01); A61K 31/194 (2006.01); A61K 31/20 (2006.01); A61K 31/203 (2006.01); A61K 31/315 (2006.01); A61K 31/4406 (2006.01); A61K 31/455 (2006.01); A61K 31/555 (2006.01); A61K 31/665 (2006.01); A61K 31/7048 (2006.01); A61Q 19/08 (2006.01); A61K 31/7028 (2006.01); A61K 31/7042 (2006.01); A61K 31/7052 (2006.01)
CPC A61K 31/7056 (2013.01) [A61K 8/361 (2013.01); A61K 8/362 (2013.01); A61K 8/4926 (2013.01); A61K 8/55 (2013.01); A61K 8/58 (2013.01); A61K 8/602 (2013.01); A61K 9/0014 (2013.01); A61K 31/194 (2013.01); A61K 31/20 (2013.01); A61K 31/203 (2013.01); A61K 31/315 (2013.01); A61K 31/4406 (2013.01); A61K 31/455 (2013.01); A61K 31/555 (2013.01); A61K 31/665 (2013.01); A61K 31/7048 (2013.01); A61Q 19/08 (2013.01); A61K 31/7028 (2013.01); A61K 31/7042 (2013.01); A61K 31/7052 (2013.01); A61K 2800/59 (2013.01)] 26 Claims
 
1. A kit comprising:
1) a composition comprising
a) a first anti-acne compound;
b) a second anti-acne compound, wherein each of the first and second anti-acne compounds are selected from the group consisting of azelaic acid, clindamycin, niacinamide, tretinoin, and zinc pyrithione, or a pharmaceutically acceptable salt thereof; and
c) an anti-photoaging compound, wherein the anti-photoaging compound is selected from the group consisting of azelaic acid, niacinamide, and ascorbyl phosphate, or a pharmaceutically acceptable salt thereof,
wherein the first anti-acne compound, the second anti-acne compound, and the anti-photoaging compound are three different compounds;
2) a sealed container for housing the composition; and
3) instructions for use.